Latest News and Press Releases
Want to stay updated on the latest news?
-
Vironexis Biotherapeutics launched today with FDA Clearance of IND application for first-ever clinical trial of an AAV-delivered cancer immunotherapy.
-
Osteoarthritis Therapeutics Market Size to Reach USD 21.77 Billion by 2033, Says The Brainy Insights
Newark, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The osteoarthritis therapeutics market is focused on the development, distribution, and utilization of treatments for osteoarthritis (OA), a degenerative...
-
ORKA-001, a novel half-life extended IL-23p19 monoclonal antibody (mAb), first-in-human dosing now expected first quarter 2025 ORKA-002, a novel half-life extended IL-17A/F mAb, first-in-human...
-
Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and existing investors MANCHESTER, United Kingdom, Sept. 12, 2024 (GLOBE...
-
Atana Wins Two Brandon Hall Group HCM Excellence Awards
-
Oakland, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- New research from Great Place To Work® reveals that workplaces where employees have equal opportunities for growth, recognition, and time with...
-
Rockville, MD , Sept. 12, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global Anionic Dispersants Market is estimated to reach a...
-
STAMFORD, Conn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the home furnishing brand best known for its Sactionals, The World's Most...
-
Boston, MA, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Circe, a carbon-negative manufacturing company, announced today a $5M Seed Round. Investors in this round include ReGen Ventures, Undeterred Capital,...
-
PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...